Eduardo Dávila

2.8k total citations
61 papers, 2.2k citations indexed

About

Eduardo Dávila is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Eduardo Dávila has authored 61 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology, 24 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Eduardo Dávila's work include Immune Cell Function and Interaction (20 papers), Immunotherapy and Immune Responses (18 papers) and CAR-T cell therapy research (17 papers). Eduardo Dávila is often cited by papers focused on Immune Cell Function and Interaction (20 papers), Immunotherapy and Immune Responses (18 papers) and CAR-T cell therapy research (17 papers). Eduardo Dávila collaborates with scholars based in United States, Japan and France. Eduardo Dávila's co-authors include Sabina Kaczanowska, Esteban Celis, Ann Mary Joseph, Degui Geng, Ratika Srivastava, Richard B. Kennedy, Ajay Jain, Liqin Zheng, Koji Tamada and Navneeta Bansal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Eduardo Dávila

60 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eduardo Dávila United States 24 1.3k 748 674 218 181 61 2.2k
David Anz Germany 26 1.5k 1.1× 651 0.9× 758 1.1× 104 0.5× 195 1.1× 54 2.3k
Soyoung Oh United States 17 1.5k 1.1× 759 1.0× 574 0.9× 159 0.7× 179 1.0× 20 2.2k
Yoshihiro Miyahara Japan 21 1.3k 1.0× 839 1.1× 488 0.7× 118 0.5× 108 0.6× 61 1.9k
Lisa M. Ebert Australia 29 1.4k 1.1× 950 1.3× 644 1.0× 103 0.5× 79 0.4× 54 2.4k
Stephen H. Wrzesinski United States 13 1.0k 0.8× 872 1.2× 705 1.0× 130 0.6× 96 0.5× 20 2.1k
Brian M. Iritani United States 27 936 0.7× 927 1.2× 1.3k 1.9× 206 0.9× 288 1.6× 45 2.7k
Amy E. Moran United States 22 1.8k 1.3× 880 1.2× 698 1.0× 153 0.7× 125 0.7× 46 2.9k
Ryoji Ito Japan 23 1.0k 0.8× 647 0.9× 547 0.8× 336 1.5× 148 0.8× 102 2.1k
Juan Dubrot Spain 25 1.4k 1.1× 841 1.1× 525 0.8× 153 0.7× 276 1.5× 45 2.1k
Jillian L. Astarita United States 12 1.2k 0.9× 1.2k 1.6× 900 1.3× 190 0.9× 231 1.3× 17 2.7k

Countries citing papers authored by Eduardo Dávila

Since Specialization
Citations

This map shows the geographic impact of Eduardo Dávila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Dávila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Dávila more than expected).

Fields of papers citing papers by Eduardo Dávila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Dávila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Dávila. The network helps show where Eduardo Dávila may publish in the future.

Co-authorship network of co-authors of Eduardo Dávila

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Dávila. A scholar is included among the top collaborators of Eduardo Dávila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Dávila. Eduardo Dávila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Yi, Yuki Fujiwara, Yujie Guo, et al.. (2025). CD93 blockade promotes effector T-cell infiltration and facilitates adoptive cell therapy in solid tumors. Journal for ImmunoTherapy of Cancer. 13(1). e010554–e010554. 3 indexed citations
2.
Wilky, Breelyn A., Alessandra Maleddu, Dexiang Gao, et al.. (2025). A Single-Arm Phase 2 Trial of Doxorubicin Plus Zalifrelimab (Anti–CTLA-4 Antibody) and Balstilimab (Anti–PD-1 Antibody) in Advanced/Metastatic Soft Tissue Sarcomas. Clinical Cancer Research. 31(14). 2945–2956. 1 indexed citations
3.
Haverkos, Bradley M., Jasmine M. Zain, Manali Kamdar, et al.. (2023). Frontline chemoimmunotherapy with nivolumab and dose-adjusted EPOCH in peripheral T-cell lymphoma: a phase 1 trial. Blood Advances. 8(3). 708–711. 2 indexed citations
4.
Kent, Andrew, et al.. (2021). Naturally Occurring Genetic Alterations in Proximal TCR Signaling and Implications for Cancer Immunotherapy. Frontiers in Immunology. 12. 658611–658611. 6 indexed citations
5.
Guo, Jitao, et al.. (2019). An Anticancer Drug Cocktail of Three Kinase Inhibitors Improved Response to a Dendritic Cell–Based Cancer Vaccine. Cancer Immunology Research. 7(9). 1523–1534. 13 indexed citations
6.
Connolly, Nina P., Amol C. Shetty, Jesse A. Stokum, et al.. (2018). Cross-species transcriptional analysis reveals conserved and host-specific neoplastic processes in mammalian glioma. Scientific Reports. 8(1). 1180–1180. 18 indexed citations
7.
Natarajan, Karthika, Rena G. Lapidus, Rossana Trotta, et al.. (2017). Concurrent Inhibition of Pim and FLT3 Kinases Enhances Apoptosis of FLT3-ITD Acute Myeloid Leukemia Cells through Increased Mcl-1 Proteasomal Degradation. Clinical Cancer Research. 24(1). 234–247. 36 indexed citations
8.
Kaczanowska, Sabina, Ann Mary Joseph, Jitao Guo, et al.. (2017). A Synthetic CD8α:MyD88 Coreceptor Enhances CD8+ T-cell Responses to Weakly Immunogenic and Lowly Expressed Tumor Antigens. Cancer Research. 77(24). 7049–7058. 12 indexed citations
9.
Tsai, Alexander K., et al.. (2017). A Multikinase and DNA-PK Inhibitor Combination Immunomodulates Melanomas, Suppresses Tumor Progression, and Enhances Immunotherapies. Cancer Immunology Research. 5(9). 790–803. 36 indexed citations
10.
Dávila, Eduardo, et al.. (2017). Translational effects and coding potential of an upstream open reading frame associated with DOPA Responsive Dystonia. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(6). 1171–1182. 5 indexed citations
11.
Joseph, Ann Mary, Ratika Srivastava, Jovanny Zabaleta, & Eduardo Dávila. (2016). Cross-talk between 4-1BB and TLR1–TLR2 Signaling in CD8+ T Cells Regulates TLR2′s Costimulatory Effects. Cancer Immunology Research. 4(8). 708–716. 11 indexed citations
12.
Geng, Degui, Sabina Kaczanowska, Alexander C. Tsai, et al.. (2015). TLR5 Ligand–Secreting T Cells Reshape the Tumor Microenvironment and Enhance Antitumor Activity. Cancer Research. 75(10). 1959–1971. 30 indexed citations
13.
Li, Zhaoyang, Ronald B. Gartenhaus, Ann Mary Joseph, et al.. (2015). Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies. Journal of Clinical Investigation. 125(3). 1081–1097. 56 indexed citations
14.
Jain, Ajay, Sabina Kaczanowska, & Eduardo Dávila. (2014). IL-1 Receptor-Associated Kinase Signaling and Its Role in Inflammation, Cancer Progression, and Therapy Resistance. Frontiers in Immunology. 5. 553–553. 126 indexed citations
15.
Smith, Elizabeth, et al.. (2013). Neuroimmune semaphorin 4A as a drug and drug target for asthma. International Immunopharmacology. 17(3). 568–575. 20 indexed citations
16.
Srivastava, Ratika, Degui Geng, Yingjia Liu, et al.. (2012). Augmentation of Therapeutic Responses in Melanoma by Inhibition of IRAK-1,-4. Cancer Research. 72(23). 6209–6216. 67 indexed citations
17.
Tamada, Koji, Degui Geng, Yukimi Sakoda, et al.. (2012). Redirecting Gene-Modified T Cells toward Various Cancer Types Using Tagged Antibodies. Clinical Cancer Research. 18(23). 6436–6445. 216 indexed citations
18.
McAleer, Jeremy P., Sun Mi Choi, Kong Chen, et al.. (2012). Regenerating islet-derived 3-gamma regulates pulmonary Th17 immunity by altering the gut microbiome (120.37). The Journal of Immunology. 188(1_Supplement). 120.37–120.37. 1 indexed citations
19.
Geng, Degui, Liqin Zheng, Ratika Srivastava, et al.. (2010). Amplifying TLR-MyD88 Signals within Tumor-Specific T Cells Enhances Antitumor Activity to Suboptimal Levels of Weakly Immunogenic Tumor Antigens. Cancer Research. 70(19). 7442–7454. 37 indexed citations
20.
Kobayashi, Hiroya, Richard B. Kennedy, Jun Lü, Eduardo Dávila, & Esteban Celis. (2000). MHC-Binding Peptides as Immunotherapeutics for Cancer. Immunological Investigations. 29(2). 105–110. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Anz Breakdown of academic impact, for papers by Soyoung Oh Breakdown of academic impact, for papers by Yoshihiro Miyahara Breakdown of academic impact, for papers by Lisa M. Ebert Breakdown of academic impact, for papers by Stephen H. Wrzesinski Breakdown of academic impact, for papers by Brian M. Iritani Breakdown of academic impact, for papers by Amy E. Moran Breakdown of academic impact, for papers by Ryoji Ito Breakdown of academic impact, for papers by Juan Dubrot Breakdown of academic impact, for papers by Jillian L. Astarita
Rankless by CCL
2026